openPR Logo
Press release

What Factors Are Affecting The Effect of Cancer Treatment?

What Factors Are Affecting The Effect of Cancer Treatment?

With social development and medical advances, people are living longer, but with that, many diseases are becoming more common, such as cancer. In 2020, there will be 19.3 million new cases of cancer and nearly 10 million deaths worldwide; and by 2040, the number of new cases is expected to reach 28.4 million, an increase of 47% from 2020.

Unlike common diseases such as colds and coughs, cancer is a more significant disease with a high mortality rate. Globally, cancer causes the second largest number of deaths after cardiovascular disease.

What factors can affect the effectiveness of cancer treatment?

The effectiveness of cancer treatment is influenced by a number of factors, such as the type and stage of cancer (how much it has spread in the body), the type of treatment, the characteristics of the cancer cells, and the lifestyle after treatment.

Types of cancer

Cancer is a general term for a group of diseases, not a single disease, but an umbrella term for hundreds of different diseases. The basic characteristic of these diseases is uncontrolled cell growth, but each type of cancer and each person's specific cancer is unique and has its own set of problems.

Some types of cancer can be treated with excellent results, such as breast, prostate and thyroid cancers where 5-year survival rates after treatment have been 90% or higher. Some cancers still have a high mortality rate, such as pancreatic cancer, which is known as the king of cancers, and still have a low survival rate.

Cancer Staging

Usually, the earlier a cancer is detected, the less likely it is to metastasize, and the better the treatment outcome. Early stage cancers have a higher remission rate than the same type of advanced cancer. For example, early stage breast cancer, lung cancer, colorectal cancer, gastric cancer, prostate cancer, etc., are more likely to go into remission after surgery, or surgery combined with chemotherapy, radiotherapy, targeted therapy or immunotherapy than the same type of advanced cancer.

Treatment modalities

Although with medical advances, cancer treatment modalities, including surgery, radiotherapy, chemotherapy, targeted therapy and immunotherapy, have also been developed and matured. The tolerance and response of cancer patients to different treatment modalities vary, and the treatment effect of cancer can be very different.

Tolerance refers to an adaptive state and result of the body's response to drugs. If cancer patients lack tolerance to effective treatment modalities or have poor overall health, treatment causes more side effects than treatment effects, which can also lead to poorer treatment outcomes.

In addition, for certain types of cancer, such as pancreatic cancer, there is still the dilemma of difficult surgery and lack of effective adjuvant treatment.

Cancer cell characteristics

The characteristics of cancer cells in patients with the same type of cancer can be very different, including the growth rate of cancer cells, invasive ability and sensitivity to drugs. The effectiveness of cancer treatment can also vary greatly depending on the characteristics of cancer cells.

Lifestyle

Scientists believe that factors that can increase the risk of cancer may also promote the recurrence of cancer after treatment. If a healthy lifestyle is adopted after treatment, including healthy diet, regular exercise, smoking cessation and alcohol cessation, it will help prevent cancer recurrence, prolong the remission period and improve the survival rate.

Although cancer is still difficult to be completely cured, with the deepening of research and the development of medicine, people have more knowledge and understanding of cancer. Hopefully, in the near future, cancer will no longer be a phobic disease and people will be able to get better survival after treatment.

PEG is an important development in anti-cancer therapy. PEGylation has the ability to enhance the retention time of the therapeutics like proteins, which consequently improves their therapeutic potential. As a professional PEG supplier, Biochempeg can provide variety quantities of high quality functionalized PEGs, which are essential for PEGylated therapeutic proteins.

Biochempeg Scientific Inc.
108 Water Street, Room 4D, Watertown, MA 02472, USA
TEL: 1-857-366-6766
Fax: 617-206-9595
Email: sales@biochempeg.com
Website: https://www.biochempeg.com

Biochempeg is a biotechnology-oriented company in Watertown, Massachusetts. We are dedicated to manufacturing and supplying high purity polyethylene glycol (PEG) derivatives and reagents, monodisperse PEG, Click Chemistry reagents,  PEGylation services and  custom PEG derivative synthesis to clients worldwide. These PEG reagents have been widely used in bioconjugation, antibody-drug conjugates (ADCs) therapeutic, drug delivery and diagnostics field. 

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What Factors Are Affecting The Effect of Cancer Treatment? here

News-ID: 2342860 • Views: 141

More Releases from Biochempeg Scientific Inc.

Sacituzumab govitecan shows promise in treating the most aggressive type of brea …
A unique antibody drug conjugate (ADC), which delivers a high dose of a cancer-killing drug to tumor cells through a targeted antibody, has been found in a global phase 3 clinical study to nearly double the survival time of patients with refractory metastatic triple-negative breast cancer. The study of the ADC drug sacituzumab govitecan (SG), for which Massachusetts General Hospital (MGH) was a lead clinical research site after serving as
ADC Has Curative Effect On Cell Surface Protein In Neuroblastoma
Physician-scientists in the Cancer Center at Children's Hospital of Philadelphia (CHOP) have developed a preclinical, potent therapy attached to an antibody that targets a surface protein expressed in most childhood neuroblastomas, effectively killing cancer cells. The researchers published their findings today in Science Translational Medicine. In 2008, researchers discovered mutations in the anaplastic lymphoma kinase (ALK) gene as the major cause of the inherited form of neuroblastoma and showed that these same mutations
The Advantages of Monodisperse PEG In Drug Development?
Monodisperse PEG products usually are organic compounds with a molecular weight of less than 1000. Monodispersed PEG linkers are pure compounds with a single molecular weight. In contrast, polydisperse PEGs linkers contain variations in molecular weight with an average molecular weight. The use of polydisperse PEGs linkers in drug development has led to problems in biological applications due to steric hindrance and binding. With advancements in both synthetic and purification chemistry over the
PEG Products Used As Ingredients In Pfizer-BioNTech COVID-19 Vaccine
The Pfizer-BioNTech COVID-19 mRNA vaccine (Tozinameran or BNT162b2) is used to protect against COVID-19. This disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The vaccine is approved for people who are 12 years of age and older. Its safety and effectiveness in people younger than 12 years of age have not yet been established. Health Canada first authorized this vaccine with conditions on December 9, 2020, under the Interim

All 5 Releases


More Releases for PEG

PEG-12 Dimethicone Market: Competitive Dynamics & Global Outlook 2025
LP INFORMATION recently released a research report on the PEG-12 Dimethicone market analysis, which studies the PEG-12 Dimethicone's industry coverage, current market competitive status, and market outlook and forecast by 2025. Global “PEG-12 Dimethicone Market 2020-2025” Research Report categorizes the global PEG-12 Dimethicone market by key players, product type, applications and regions,etc. The report also covers the latest industry data, key players analysis, market share, growth
PEG-10 Dimethicone Market: Competitive Dynamics & Global Outlook 2025
LP INFORMATION recently released a research report on the PEG-10 Dimethicone market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global PEG-10 Dimethiconemarket by key players, product type, applications and regions,etc. The main objective of this market research is to help the readers understand the structure of PEG-10 Dimethiconemarket, market definition, overview, industry opportunities and trends, investment
Application of PEG In Click Chemistry
Polyethylene glycol (PEG) is a biocompatible, synthetic, hydrophilic polyether compound that has many applications, mostly in the medical industry, but also in the chemical and industrial sectors. The synthesis of PEG is done by polymerizing ethylene oxide, the main ingredient in antifreeze, using a ring-opening technique, which allows for PEGs of a range of molecular weights and molecular weight distributions to be constructed. This range in weights is what makes
What Are PEG Linkers?
Hydrophilic poly(ethylene glycol) or PEG-linkers are particularly attractive as a linker for conjugation. Water solubility, lack of toxicity; low immunogenicity and well defined chain lengths and molecular weights are specific characteristics of PEG moieties relevant to pharmaceutical applications. Hydrophilic linkers The link between the antibody and the cytotoxic agent plays a critical role in development of antibody-drug conjugates. The nature of the linker can significantly affect the potency, selectivity, and the pharmacokinetics of
Biochempeg developed a series of PEG compounds used for Semaglutide
Type 2 diabetes is the most common form of diabetes. Semaglutide is an agonist of glucagon-like peptide-1 (GLP-1) receptor that is developed to treat type 2 diabetes. It reduces blood sugar via increasing the production of insulin. Biochempeg has developed and can supply some key intermediates of Semaglutide. Semaglutide(trade names: Rybelsus,Ozempic) is a medication for the treatment of type 2 diabetes. It was discovered in 2012, by a team of researchers
Global PEG Stearate Market Huge Growth Opportunity between 2020-2025
LP INFORMATION recently released a research report on the PEG Stearate market analysis, which studies the PEG Stearate's industry coverage, current market competitive status, and market outlook and forecast by 2025. Global "PEG Stearate Market 2020-2025" Research Report categorizes the global PEG Stearate market by key players, product type, applications and regions,etc. The report also covers the latest industry data, key players analysis, market share, growth